Trials / Completed
CompletedNCT01715493
Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom
Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom: a Randomised Placebo-controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 84 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to assess the effectiveness for small airway inflammation of 4 weeks lysozyme administration in Chronic Obstructive Pulmonary Disease (COPD) and/or asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lysozyme 90 mg | Lysozyme 90 mg three times daily for 4 weeks followed by placebo for 4 weeks (plus usual COPD medication) |
| DRUG | Placebo | Lysozyme Matching Placebo three times daily for 4 weeks followed by Lysozyme 90 mg three times daily for 4 weeks (plus usual COPD medication) |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-12-01
- Completion
- 2014-01-01
- First posted
- 2012-10-29
- Last updated
- 2014-07-18
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01715493. Inclusion in this directory is not an endorsement.